A Phase 1, Fixed Sequence, Cross-Over Study To Estimate The Effect Of Multiple Doses Of Ketoconazole On The Single Dose Pharmacokinetics Of Crizotinib (PF-02341066) In Healthy Volunteers.

Trial Profile

A Phase 1, Fixed Sequence, Cross-Over Study To Estimate The Effect Of Multiple Doses Of Ketoconazole On The Single Dose Pharmacokinetics Of Crizotinib (PF-02341066) In Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 31 May 2013

At a glance

  • Drugs Crizotinib (Primary) ; Ketoconazole
  • Indications Cancer; Non-small cell lung cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 17 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Aug 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 26 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top